MetaCap

Aptevo Therapeutics (APVO) vs Jupiter Neurosciences (JUNS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Jupiter Neurosciences is the larger company by market cap ($1.6 million vs $1.4 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

APVO-78.04%JUNS-56.51%
+23%-30%-83%
Oct 7, 20261 yearNov 20, 2026
APVO-77.42%JUNS-56.67%
+9%-36%-82%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

APVO versus JUNS key metrics
MetricAPVOJUNS
Share price$0.4041$1.24
Market cap$1.40M$1.63M
1-day change-2.37%-18.75%
P/E ratio (TTM)0.01—
Forward P/E—20.58
EPS (TTM)$66.96$-22.53
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$21.80K
Net income (latest FY)$-25.97M$-8.64M
Gross margin—80.59%
Operating margin—-40873.19%
Net margin—-39662.77%
52-week high$25.56$97.73
52-week low$0.377$1.20
Distance from 52-week high-98.42%-98.74%
Analyst consensusnone—
Avg. price target upside+6210.32%—
Average volume132.90K69.86K
Shares outstanding3.46M1.32M
Employees335
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Aptevo Therapeutics

APVO stock →

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.

Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees

About Jupiter Neurosciences

JUNS stock →

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

APVO vs JUNS FAQ

Which is bigger, Aptevo Therapeutics or Jupiter Neurosciences?

Jupiter Neurosciences (JUNS) is larger, with a market capitalization of $1.63M compared with $1.40M for Aptevo Therapeutics (APVO).

Are Aptevo Therapeutics and Jupiter Neurosciences in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons